Skip to content

Desara Blue TVez 3.0 CAL-DS01BTV30 (UDI 00890594000087)Recalls & reported problems

Caldera Medical, Inc. · Desara Blue TVez 3.0mm for the treatment of female stress urinary incontinence (SUI) or mixed incontinence · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00890594000087), received between Oct 29, 2025 and Oct 29, 2025 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Hyperplasia1
  • Hypersensitivity/Allergic reaction1
  • Pain1
  • Sexual Dysfunction1
  • Skin Discoloration1
  • Swelling/ Edema1
  • Unspecified Nervous System Problem1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 29, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE FDA (FOOD AND DRUG ADMINISTRATION) SENT A MEDICAL DEVICE REPORT UNDER MW5162638. PT HISTORY OF RENAL CONGENITAL DEFECTS. TOLD MUS WAS SAFE AND GOLD STANDARD. SURGEON RECOMMENDED MUS AFTER POP REPAIR, STATING URETHRA WAS "KINKED" AND WOULD NEED SUPPORT AFTER POP (PELVIC ORGAN PROLAPSE) REPAIR. PT HAD THIN VAG TISSUES. SURGEON PLACED MUS A LITTLE DIFFERENTLY (PER SURGEON). PT COMPLAINED IN POST-OP RECOVERY OF UNUSUAL SEVERE PAIN, SWELLING, CLOTS, BLEEDING, AND SEVERE URETHRAL SWELLING. PT DISMISSED AND TOLD ALL NORMAL. PT REPORTED SEVERE TISSUE AND NERVE PAIN, CLINICAL SWELLING, MESH PALPABLE W/ INTERNAL EXAM, INABILITY TO SIT, FOR MONTHS FOLLOWING MUS AND POP SX. PT ADVOCATED FOR HELP COMPLAINING OF CONT. POST SURGICAL PAIN, INABILITY TO SIT, URETHRAL/CLITORAL PAIN. PT DISMISSED. PT OUTSOURCED TO ANOTHER STATE FOR MEDICAL CARE, AND TO HAVE MESH REMOVED. PT ALLERGIC TO MESH AND HAD DX MESH COMPLICATIONS. PT SUFFERED SEVERE PAIN, SWELLING, HYPERPLASIA, NERVE PAIN, CLINICAL SWELLING AND REDNESS. PT DEVELOPED SEVERE INTERNAL BLEEDING DURING MESH REMOVAL SX. PT NEEDED RE-HOSPITALIZATION FOR BLOOD TRANSFUSION FROM MESH REMOVAL. PT SUFFERS WITH SCAR TISSUE AND ADHESIONS FROM MESH AND M

    Patient problems: Hyperplasia; Hypersensitivity/Allergic reaction; Pain; Sexual Dysfunction; Skin Discoloration; Swelling/ Edema; Unspecified Nervous System Problem

    MAUDE report 23416527 ↗

Other Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator devices

All Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page